Research and News Involving:
Health Equity
Adult, Cincinnati Children's Hospital Medical Center, Current Research, Dr. Abonia, Drug, Health Equity, Immune Disorder, Rare Disease
Repurposing a Rare Disease Treatment for the Immune Disorder Eosinophilic Esophagitis Principal Investigator: Dr. J. Pablo Abonia Disease: Eosinophilic esophagitis Research Description: Eosinophilic esophagitis (EoE) is a rare disease caused when the immune system...
Completed Research, CureAccelerator Live!, Dr. Gordon, Drug, Health Equity, Oncology, Pediatric, Rare Disease, The University of Texas MD Anderson Cancer Center
Enhancing Treatment Response in Recurrent/Metastatic Osteosarcoma with Hydroxychloroquine Principal Investigator: Dr. Nancy Gordon Disease: Osteosarcoma Research Description: Osteosarcoma (OS) is an orphan disease affecting approximately 400 children and adolescents...
Big Leap Research, Current Research, Dr. Nguyen, Drug, Health Equity, Liver Disease, LMICs, Pediatric, Rare Disease, ReGRoW, Vietnam National Children’s Hospital
Improving Outcomes for the Rare Liver Disease Biliary Atresia with a Cancer Drug in Vietnam Principal Investigator: Dr. Anh-Hoa Pham Nguyen Disease: Biliary atresia Research Description: Biliary atresia (BA) is a rare congenital liver disease that causes bile duct...
Adult, CureAccelerator Live!, Dr. Phillips, Drug, Health Equity, Oncology, Rare Disease, University of Michigan
Improving Patient Response in Mantle Cell Lymphoma with Venetoclax Principal Investigator: Dr. Tycel Phillips Disease: Mantle cell lymphoma Research Description: Mantle cell lymphoma (MCL) is a rare form of non-Hodgkin lymphoma (NHL) that is diagnosed mostly in older...
Adult, Chicago, Completed Research, Dr. Meltzer, Health Equity, Infectious Disease, Nutraceutical, University of Chicago
Can Vitamin D Reduce the Burden of COVID-19 in Chicago? Principal Investigator: Dr. David Meltzer Disease: COVID-19 Research Description: COVID-19 infections, caused by the SARS-CoV-2 coronavirus, has resulted in a global pandemic. The burden of COVID-19 in the US...
Adult, Completed Research, Dr. Hamaluba, Drug, Health Equity, KEMRI-Wellcome Trust Research Programme, LMICs, Other, ReGRoW
Testing the Safety of a Metal Poisoning Drug to Treat Snakebite in Kenya Principal Investigator: Dr. Mainga Hamaluba Disease: Snakebite Research Description: Every year, over 5 million people worldwide suffer from snakebite, which is fatal in over 100,000 individuals....
Adult, Completed Research, Drug, Health Equity, Infectious Disease, LMICs, Obafemi Awolowo University & Teaching Hospitals Complex, Prof. Adewole, ReGRoW
Treating Tuberculosis with the Lipid Lowering Drug Atorvastatin in Nigeria Principal Investigator: Prof. Olanisun Olufemi Adewole Disease: Tuberculosis Research Description: Tuberculosis (TB) is caused by a bacterial infection and is the leading infectious disease...
Current Research, Dr. Chang, Drug, George Washington University, Health Equity, Infectious Disease, LMICs, Mid-Atlantic, Pediatric
Repurposing a Flu Treatment for Severe Dengue Patients in Colombia Principal Investigator: Dr. Aileen Chang Disease: Dengue Fever Research Description:Dengue viruses (DenV) are among the leading causes of pediatric morbidity and mortality globally, with 96 million...
Completed Research, CureAccelerator Live!, Dr. Budree, Dr. Osman, GI, Health Equity, LMICs, Longest Day of Golf, Openbiome, Other, Pediatric
The THRIVE Study: Repurposing Fecal Microbiota Transplantation for the Treatment of Pediatric Malnutrition in South Africa Principal Investigator: Dr. Majdi Osman, Dr. Shrish Budree Disease: Severe and Moderate Pediatric Malnutrition Research Description: Globally,...
